Skip to Content
You are currently on the new version of our website. Access the old version .
PharmaceuticalsPharmaceuticals
  • Review
  • Open Access

11 September 2025

17 Pages

Advances in Pharmacological Properties, Molecular Mechanisms, and Bioavailability Strategies of Chlorogenic Acid in Cardiovascular Diseases Therapy

,
,
,
,
,
,
,
,
…
1
Department of Cardiology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China
2
Department of Cardiology, Changzhou Medical Center, Nanjing Medical University, Changzhou 213003, China
3
Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
*
Authors to whom correspondence should be addressed.
This article belongs to the Section Pharmacology

Abstract

Cardiovascular diseases (CVDs), a group of global diseases, are characterized by high morbidity and mortality, imposing a significant burden on clinical practice. Chlorogenic acid (CGA), a natural compound composed of caffeic acid and quinic acid, is widely found in and extracted from plants such as Lonicera japonica (honeysuckle), Eucommia ulmoides (hardy rubber tree), tea leaves, and coffee beans. In recent years, increasing attention has been directed towards the pharmacological mechanisms of CGA in the treatment of CVDs. This review comprehensively summarizes the current knowledge on the preparation, metabolic pathways, pharmacological effects, and safety profile of CGA. Furthermore, it systematically analyzes the biological effects and molecular targets of CGA in the cardiovascular therapy and highlights strategies to enhance its bioavailability. These insights aim to provide a scientific basis for future basic research and clinical applications.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.